Difference between revisions of "Oak"
(Added Western Medicine category) |
(Linked book title to Google Books) |
||
Line 8: | Line 8: | ||
'''Quote Paraph''': "the tonics he (de Horta in Mexico in 1754) recommended to restore strength included oak flowers, sandal wood, sassafras and guaiacum."<BR> | '''Quote Paraph''': "the tonics he (de Horta in Mexico in 1754) recommended to restore strength included oak flowers, sandal wood, sassafras and guaiacum."<BR> | ||
'''Sec Auth''': Eadie MJ and Bladin PF<BR> | '''Sec Auth''': Eadie MJ and Bladin PF<BR> | ||
− | '''Title''': A Disease Once Sacred. John Libbey & Company Ltd, 2001<BR> | + | '''Title''': [http://books.google.com/books?id=OaxrAAAAMAAJ&dq=A+Disease+Once+Sacred.+John+Libbey+%26+Company+Ltd,+2001&as_pt=BOOKS&hl=&source=gbs_api A Disease Once Sacred. John Libbey & Company Ltd, 2001]<BR> |
'''Page''': 191<BR> | '''Page''': 191<BR> | ||
'''Source''': A Disease Once Sacred, John Libbey & Company Ltd, 2001, M.J. Eadie and P.F. Bladin<BR> | '''Source''': A Disease Once Sacred, John Libbey & Company Ltd, 2001, M.J. Eadie and P.F. Bladin<BR> |
Latest revision as of 13:14, 8 April 2015
Oak is a non-scientific common name that may refer to a number of plant species and varieties.
Contents
Nomenclature
Other Names:
Historical Use of Oak
Oak in Traditional Chinese Medicine
Description
Historical Use of Oak in Western Medicine
Quote Paraph: "the tonics he (de Horta in Mexico in 1754) recommended to restore strength included oak flowers, sandal wood, sassafras and guaiacum."
Sec Auth: Eadie MJ and Bladin PF
Title: A Disease Once Sacred. John Libbey & Company Ltd, 2001
Page: 191
Source: A Disease Once Sacred, John Libbey & Company Ltd, 2001, M.J. Eadie and P.F. Bladin
Complete: Eadie MJ, Bladin PF. A disease once sacred: a history of the medical understanding of epilepsy. Eastleigh: John Libbey; 2001. p. 191.
Primary Source:
Background
Synonymns for Oak
Patent Medicines and Medicines with Multiple Ingredients that include Oak
Pharmaceutical Information
Chemical Constituents
Evidence or the Use of Oak in the Treatment of Epilepesy
Basic Science
Animal Studies
Cohort, Case-Control and Non-Randomized Trials
Randomized Controlled Trials
Meta-Analysis
1st Five Results: pubmed search
Jay Idler, Onur Turkoglu, Kara Patek, Sean Stuart, Birce Taskin, Lalitha Sivaswamy, Amy Whitten
Neurocutaneous Disorders in Pregnancy.
Obstet Gynecol Surv: 2023, 78(10);606-619
[PubMed:37976316]
[WorldCat.org]
[DOI]
(I p)
Cassidy T Burke, Iuliia Vitko, Justyna Straub, Elsa O Nylund, Agnieszka Gawda, Kathryn Blair, Kyle A Sullivan, Lara Ergun, Matteo Ottolini, Manoj K Patel, Edward Perez-Reyes
EpiPro, a Novel, Synthetic, Activity-Regulated Promoter That Targets Hyperactive Neurons in Epilepsy for Gene Therapy Applications.
Int J Mol Sci: 2023, 24(19);
[PubMed:37833914]
[WorldCat.org]
[DOI]
(I e)
Anto I Bagić, Susan M Bowyer, Richard C Burgess, Michael E Funke, Andrea Lowden, Ismail S Mohamed, Tony Wilson, Wenbo Zhang, Andrew J Zillgitt, Jeffrey R Tenney
Role of optically pumped magnetometers in presurgical epilepsy evaluation: Commentary of the American Clinical Magnetoencephalography Society.
Epilepsia: 2023, 64(12);3155-3159
[PubMed:37728519]
[WorldCat.org]
[DOI]
(I p)
Elizabeth Martina Bebin, Jurriaan M Peters, Brenda E Porter, Tarrant O McPherson, Sarah O'Kelley, Mustafa Sahin, Katherine S Taub, Rajsekar Rajaraman, Stephanie C Randle, William M McClintock, Mary Kay Koenig, Mike D Frost, Hope A Northrup, Klaus Werner, Danielle A Nolan, Michael Wong, Jessica L Krefting, Fred Biasini, Kalyani Peri, Gary Cutter, Darcy A Krueger, PREVeNT Study Group
Early Treatment with Vigabatrin Does Not Decrease Focal Seizures or Improve Cognition in Tuberous Sclerosis Complex: The PREVeNT Trial.
Ann Neurol: 2023;
[PubMed:37638552]
[WorldCat.org]
[DOI]
(I a)
Kyle A Sullivan, Iuliia Vitko, Kathryn Blair, Ronald P Gaykema, Madison J Failor, Jennifer M San Pietro, Deblina Dey, John M Williamson, Ruth L Stornetta, Jaideep Kapur, Edward Perez-Reyes
Drug-Inducible Gene Therapy Effectively Reduces Spontaneous Seizures in Kindled Rats but Creates Off-Target Side Effects in Inhibitory Neurons.
Int J Mol Sci: 2023, 24(14);
[PubMed:37511107]
[WorldCat.org]
[DOI]
(I e)